Statins exhibit anti-tumor potential by modulating Wnt/β-catenin signaling in colorectal cancer

Sneha Tripathi1, Ekta Gupta1,2, Rutika Naik1

  • 1Laboratory of Chromatin Biology and Epigenetics, Indian Institute of Science Education and Research, Pune 411008, India.

Oncotarget
|July 21, 2025
PubMed

Insights

Statins show promise for colorectal cancer treatment by altering lipid metabolism and gene expression. They selectively modulate the Wnt/β-catenin pathway, downregulating SATB1 and upregulating SATB2, offering a potential drug repurposing strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Colorectal cancer is a leading cause of global cancer deaths, necessitating novel therapeutic strategies.
  • Drug repurposing, particularly using statins, is an emerging approach to target cancer pathways.
  • Statins, cholesterol-lowering drugs, exhibit potential anti-cancer properties.

Purpose of the Study:

  • To investigate the effects of statin treatment on colorectal cancer models.
  • To elucidate how statins influence lipid metabolism, gene expression, and proteomic profiles.
  • To determine the impact of statins on the Wnt/β-catenin signaling pathway and SATB protein family.

Main Methods:

  • Utilized colorectal cancer models to assess statin treatment effects.
  • Analyzed changes in lipid metabolism, gene expression, and proteomic profiles.
  • Investigated the modulation of the Wnt/β-catenin pathway and SATB1/SATB2 expression in 3D spheroid models.

Main Results:

  • Statin treatment selectively modulated key components of the Wnt/β-catenin signaling pathway.
  • Statin administration downregulated SATB1 (tumorigenesis promoter) and upregulated SATB2.
  • Reciprocal regulation of SATB1/SATB2 by statins induced shifts in cellular phenotypes between epithelial and mesenchymal states.

Conclusions:

  • Statins demonstrate therapeutic potential in colorectal cancer by targeting the Wnt/β-catenin pathway.
  • The observed reciprocal regulation of SATB1 and SATB2 by statins offers a novel mechanism for cancer therapy.
  • Statin repurposing should be considered for colorectal cancer treatment strategies.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K